GGrantIndex
← Search

CCTN - CONTRACEPTIVE CLINICAL TRIALS NETWORK

$490,236N01FY2014HDNIH

University Of Washington, Seattle WA

Investigators

Abstract

Conduct a Phase I clinical trial to test whether a new chemical entity such as 11-beta methyl nortestosterone dodecycarbonate will be well tolerated and will suppress gonadotropins pursuant to development of a contraceptive product for men.

View original record on NIH RePORTER →